4:27 pm Epizyme reports 2013 Collaboration revs of $68.5 mln and net loss of $3.5 mln; sees 2014 R&D expenses of approx. $75 mln and 2014 G&A expenses of approx. $20 mln
View todays social media effects on EPZM
View the latest stocks trending across Twitter. Click to view dashboard
See who Epizyme is hiring next, click here to view
